Th17 cells: A prognostic marker for MS rebound after natalizumab cessation? Haas J, Schneider K, Schwarz A, Korporal-Kuhnke M, Faller S, von Glehn F, Jarius S, Wildemann B Mult Scler. 2016 Mar 21. PMID: 27003947. Abstract CommentRecommendBookmarkWatch